HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hitoshi Takahashi Selected Research
Hitoshi Takahashi Research Topics
Disease
31
Parkinson Disease (Parkinson's Disease)
01/2018 - 03/2002
30
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2018 - 06/2003
27
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 02/2002
23
Neoplasms (Cancer)
03/2019 - 02/2002
22
Schizophrenia (Dementia Praecox)
09/2022 - 03/2002
22
Multiple System Atrophy
11/2019 - 03/2002
22
Dementia (Dementias)
10/2017 - 03/2002
17
Lewy Body Disease (Lewy Body Dementia)
01/2018 - 07/2002
15
Alzheimer Disease (Alzheimer's Disease)
08/2015 - 06/2002
14
Synucleinopathies
01/2018 - 07/2002
13
Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2016 - 06/2003
11
Major Depressive Disorder (Major Depressive Disorders)
01/2009 - 01/2002
9
Infections
01/2020 - 05/2002
9
Glioma (Gliomas)
03/2019 - 11/2005
7
Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2018 - 04/2007
7
Tauopathies
12/2015 - 08/2003
7
Frontotemporal Dementia (Semantic Dementia)
12/2013 - 04/2004
6
Exercise-Induced Allergies
10/2016 - 12/2009
6
Sepsis (Septicemia)
01/2015 - 12/2002
5
Human Influenza (Influenza)
01/2018 - 08/2003
5
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
10/2017 - 06/2002
5
Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
02/2016 - 11/2002
5
Motor Neuron Disease (Primary Lateral Sclerosis)
02/2014 - 10/2009
5
Inflammation (Inflammations)
06/2013 - 09/2008
5
Atrophy
08/2012 - 07/2003
5
Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
07/2010 - 04/2002
4
Parkinsonian Disorders (Parkinsonism)
12/2021 - 04/2004
4
Glioblastoma (Glioblastoma Multiforme)
03/2019 - 08/2003
4
Lymphoma (Lymphomas)
04/2018 - 07/2005
4
TDP-43 Proteinopathies
12/2015 - 03/2011
4
Pick Disease of the Brain (Pick's Disease)
02/2014 - 11/2002
4
Disease Progression
07/2013 - 03/2008
4
Corticobasal Degeneration
07/2010 - 05/2002
4
Nausea
01/2009 - 10/2002
3
Virus Diseases (Viral Diseases)
01/2018 - 02/2004
3
Huntington Disease (Huntington's Disease)
01/2018 - 12/2012
3
Tuberous Sclerosis (Bourneville's Disease)
01/2018 - 05/2013
3
Gliosis
04/2016 - 12/2009
3
Multiple Sclerosis
04/2016 - 09/2009
3
Proteostasis Deficiencies
01/2016 - 08/2012
3
Sarcoma (Soft Tissue Sarcoma)
01/2016 - 12/2013
3
Vasculitis (Vasculitides)
02/2014 - 12/2002
3
Hypersensitivity (Allergy)
12/2013 - 11/2011
3
Atopic Dermatitis (Atopic Eczema)
01/2013 - 11/2011
3
Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
08/2012 - 04/2007
Drug/Important Bio-Agent (IBA)
52
Proteins (Proteins, Gene)
FDA Link
09/2022 - 03/2002
22
alpha-Synuclein
IBA
08/2010 - 02/2002
19
polyglutamine
IBA
01/2018 - 11/2002
15
Antibodies
IBA
01/2016 - 02/2002
14
Ubiquitin
IBA
02/2014 - 12/2002
12
Synucleins
IBA
11/2019 - 02/2002
12
DNA-Binding Proteins (DNA Binding Protein)
IBA
01/2017 - 05/2007
10
DNA (Deoxyribonucleic Acid)
IBA
08/2015 - 02/2004
9
Milnacipran (Ixel)
FDA Link
01/2009 - 09/2003
8
Messenger RNA (mRNA)
IBA
01/2021 - 07/2003
7
Dopamine (Intropin)
FDA Link
Generic
01/2018 - 08/2002
7
Serotonin (5 Hydroxytryptamine)
IBA
01/2017 - 10/2002
7
3-Iodobenzylguanidine (Iobenguane)
IBA
09/2015 - 11/2004
7
Fluvoxamine (Luvox)
FDA Link
Generic
06/2008 - 01/2002
6
Enzymes
IBA
01/2018 - 06/2003
6
Amyloid beta-Peptides
IBA
10/2017 - 06/2002
6
Gliadin
IBA
10/2016 - 12/2009
5
RNA (Ribonucleic Acid)
IBA
01/2021 - 09/2013
5
Antidepressive Agents (Antidepressants)
IBA
01/2017 - 02/2002
5
Allergens
IBA
10/2016 - 12/2009
5
Amyloid (Amyloid Fibrils)
IBA
08/2015 - 06/2002
5
Immunoglobulin E (IgE)
IBA
12/2013 - 12/2009
5
Antipsychotic Agents (Antipsychotics)
IBA
04/2010 - 08/2002
5
Risperidone (Risperdal Consta)
FDA Link
Generic
10/2006 - 03/2002
4
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
03/2019 - 11/2014
4
Peptides (Polypeptides)
IBA
01/2018 - 12/2002
4
Steroids
IBA
08/2016 - 10/2004
4
Codon (Codons)
IBA
01/2016 - 11/2007
4
Biomarkers (Surrogate Marker)
IBA
09/2015 - 01/2007
4
Mucin-1 (CA 15-3 Antigen)
IBA
08/2014 - 12/2007
3
Neuregulin-1 (Neuregulin 1)
IBA
09/2022 - 06/2009
3
Epidermal Growth Factor (EGF)
IBA
09/2022 - 05/2005
3
Pharmaceutical Preparations
IBA
12/2021 - 09/2004
3
Ligands
IBA
04/2018 - 06/2004
3
Carrier Proteins (Binding Protein)
IBA
01/2018 - 07/2006
3
Glycoproteins (Glycoprotein)
IBA
01/2017 - 11/2005
3
Paraffin
IBA
12/2016 - 12/2014
3
Superoxide Dismutase
IBA
01/2016 - 09/2008
3
Immunoglobulin G (IgG)
IBA
11/2015 - 10/2004
3
Tubulin
IBA
09/2014 - 05/2010
3
Protein Isoforms (Isoforms)
IBA
08/2014 - 04/2004
3
Peptide Hydrolases (Proteases)
FDA Link
02/2014 - 12/2009
3
Nuclear Proteins (Protein, Nuclear)
IBA
02/2014 - 08/2008
3
Superoxide Dismutase-1
IBA
07/2013 - 10/2004
3
Antigens
IBA
01/2012 - 12/2009
3
Endopeptidase K (Proteinase K)
IBA
10/2011 - 08/2010
3
Apolipoproteins E (ApoE)
IBA
06/2011 - 07/2006
3
Neurofilament Proteins
IBA
08/2010 - 12/2007
3
Olanzapine (Zyprexa)
FDA Link
04/2008 - 08/2006
Therapy/Procedure
11
Therapeutics
08/2016 - 06/2002
5
Drug Therapy (Chemotherapy)
11/2015 - 01/2003
4
Ligation
01/2015 - 12/2002
4
Punctures
01/2015 - 12/2002
3
Radiotherapy
08/2016 - 01/2003
3
Sympathectomy (Sympathectomies)
11/2008 - 06/2005